Header Logo

Connection

Mark Klempner to Humans

This is a "connection" page, showing publications Mark Klempner has written about Humans.
Connection Strength

0.504
  1. Wang Y, Esquivel R, Flingai S, Schiller ZA, Kern A, Agarwal S, Chu J, Patel A, Sullivan K, Wise MC, Broderick KE, Hu L, Weiner DB, Klempner MS. Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice. J Infect Dis. 2019 03 15; 219(7):1146-1150.
    View in: PubMed
    Score: 0.025
  2. Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. The reply. Am J Med. 2014 Feb; 127(2):e11-2.
    View in: PubMed
    Score: 0.017
  3. Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013 Aug; 126(8):665-9.
    View in: PubMed
    Score: 0.017
  4. Klempner MS, Halperin JJ, Baker PJ, Shapiro ED, O'Connell S, Fingerle V, Wormser GP. Lyme borreliosis: the challenge of accuracy. Neth J Med. 2012 Jan; 70(1):3-5.
    View in: PubMed
    Score: 0.015
  5. Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ. Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock. N Engl J Med. 2010 Aug 19; 363(8):766-77.
    View in: PubMed
    Score: 0.014
  6. Klempner MS, Unnasch TR, Hu LT. Taking a bite out of vector-transmitted infectious diseases. N Engl J Med. 2007 Jun 21; 356(25):2567-9.
    View in: PubMed
    Score: 0.011
  7. Zhao Z, McCloud B, Fleming R, Klempner MS. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem Biophys Res Commun. 2007 Jun 29; 358(2):528-33.
    View in: PubMed
    Score: 0.011
  8. Zhao Z, Fleming R, McCloud B, Klempner MS. CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi. Infect Immun. 2007 Jun; 75(6):3062-9.
    View in: PubMed
    Score: 0.011
  9. Klempner M. Interview with Mark Klempner, MD, principal investigator, National Emerging Infectious Diseases Laboratories, and associate provost for research, Boston University School of Medicine. Biosecur Bioterror. 2006; 4(2):107-12.
    View in: PubMed
    Score: 0.010
  10. Wormser GP, Kaslow R, Tang J, Wade K, Liveris D, Schwartz I, Klempner M. Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease. J Infect Dis. 2005 Dec 01; 192(11):2020-6.
    View in: PubMed
    Score: 0.010
  11. Klempner MS, Wormser GH, Wade K, Trevino RP, Tang J, Kaslow RA, Schmid C. A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis. 2005 Sep 15; 192(6):1010-3.
    View in: PubMed
    Score: 0.010
  12. Drazen JM, Klempner MS. Disaster, water, cholera, vaccines, and hope. N Engl J Med. 2005 Feb 24; 352(8):827.
    View in: PubMed
    Score: 0.009
  13. Klempner MS, Shapiro DS. Crossing the species barrier--one small step to man, one giant leap to mankind. N Engl J Med. 2004 Mar 18; 350(12):1171-2.
    View in: PubMed
    Score: 0.009
  14. Zhao Z, Chang H, Trevino RP, Whren K, Bhawan J, Klempner MS. Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease. J Infect Dis. 2003 Oct 15; 188(8):1098-104.
    View in: PubMed
    Score: 0.008
  15. Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A, Schmid CH, Klempner MS. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology. 2003 Jun 24; 60(12):1916-22.
    View in: PubMed
    Score: 0.008
  16. Bajoria S, Antunez LR, Kumru OS, Klempner M, Wang Y, Cavacini LA, Joshi SB, Volkin DB. Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli. J Pharm Sci. 2023 07; 112(7):1832-1844.
    View in: PubMed
    Score: 0.008
  17. Li Q, Humphries F, Girardin RC, Wallace A, Ejemel M, Amcheslavsky A, McMahon CT, Schiller ZA, Ma Z, Cruz J, Dupuis AP, Payne AF, Maryam A, Yilmaz NK, McDonough KA, Pierce BG, Schiffer CA, Kruse AC, Klempner MS, Cavacini LA, Fitzgerald KA, Wang Y. Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants. Front Immunol. 2022; 13:995412.
    View in: PubMed
    Score: 0.008
  18. Ejemel M, Smith TG, Greenberg L, Carson WC, Lowe D, Yang Y, Jackson FR, Morgan CN, Martin BE, Kling C, Hutson CL, Gallardo-Romero N, Ellison JA, Moore S, Buzby A, Sullivan-Bolyai J, Klempner M, Wang Y. A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Sci Rep. 2022 06 07; 12(1):9403.
    View in: PubMed
    Score: 0.008
  19. Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis. 2002; 2(4):255-63.
    View in: PubMed
    Score: 0.008
  20. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001 Jul 12; 345(2):85-92.
    View in: PubMed
    Score: 0.007
  21. Schiller ZA, Rudolph MJ, Toomey JR, Ejemel M, LaRochelle A, Davis SA, Lambert HS, Kern A, Tardo AC, Souders CA, Peterson E, Cannon RD, Ganesa C, Fazio F, Mantis NJ, Cavacini LA, Sullivan-Bolyai J, Hu LT, Embers ME, Klempner MS, Wang Y. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. J Clin Invest. 2021 06 01; 131(11).
    View in: PubMed
    Score: 0.007
  22. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, Noring R, Weinstein A. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001 Feb 15; 110(3):217-9.
    View in: PubMed
    Score: 0.007
  23. Amcheslavsky A, Wallace AL, Ejemel M, Li Q, McMahon CT, Stoppato M, Giuntini S, Schiller ZA, Pondish JR, Toomey JR, Schneider RM, Meisinger J, Heukers R, Kruse AC, Barry EM, Pierce BG, Klempner MS, Cavacini LA, Wang Y. Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design. Sci Rep. 2021 02 02; 11(1):2751.
    View in: PubMed
    Score: 0.007
  24. Hu LT, Klempner MS. Update on the prevention, diagnosis, and treatment of Lyme disease. Adv Intern Med. 2001; 46:247-75.
    View in: PubMed
    Score: 0.007
  25. Teh AY, Cavacini L, Hu Y, Kumru OS, Xiong J, Bolick DT, Joshi SB, Gr?nwald-Gruber C, Altmann F, Klempner M, Guerrant RL, Volkin DB, Wang Y, Ma JK. Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants. Gut Microbes. 2021 Jan-Dec; 13(1):1-14.
    View in: PubMed
    Score: 0.007
  26. Ejemel M, Gawron MA, Schneider MI, Wallace A, Schiller ZA, Schneider R, Martin Iii JC, Klempner MS, Wang Y, Cavacini LA. Highly Specific Mouse Anti-Joining Chain of Human Immunoglobulin A. Monoclon Antib Immunodiagn Immunother. 2020 Dec; 39(6):228-232.
    View in: PubMed
    Score: 0.007
  27. Ejemel M, Li Q, Hou S, Schiller ZA, Tree JA, Wallace A, Amcheslavsky A, Kurt Yilmaz N, Buttigieg KR, Elmore MJ, Godwin K, Coombes N, Toomey JR, Schneider R, Ramchetty AS, Close BJ, Chen DY, Conway HL, Saeed M, Ganesa C, Carroll MW, Cavacini LA, Klempner MS, Schiffer CA, Wang Y. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction. Nat Commun. 2020 08 21; 11(1):4198.
    View in: PubMed
    Score: 0.007
  28. Klempner M. Navigating life review interviews with survivors of trauma. Oral Hist Rev. 2000 Summer-Fall; 27(2):67-83.
    View in: PubMed
    Score: 0.007
  29. Perides G, Tanner-Brown LM, Eskildsen MA, Klempner MS. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures. J Neurosci Res. 1999 Dec 15; 58(6):779-90.
    View in: PubMed
    Score: 0.007
  30. Klempner MS, Huber BT. Is it thee or me?--autoimmunity in Lyme disease. Nat Med. 1999 Dec; 5(12):1346-7.
    View in: PubMed
    Score: 0.007
  31. Klempner MS. Beyond us versus them. J Gen Intern Med. 1999 Aug; 14(8):514-5.
    View in: PubMed
    Score: 0.006
  32. Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD, Barry EM, Cavacini LA, Klempner MS, Wang Y. Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection. Infect Immun. 2018 08; 86(8).
    View in: PubMed
    Score: 0.006
  33. Perides G, Charness ME, Tanner LM, P?ter O, Satz N, Steere AC, Klempner MS. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis. 1998 Feb; 177(2):401-8.
    View in: PubMed
    Score: 0.006
  34. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol. 1997 Sep; 17(5):354-65.
    View in: PubMed
    Score: 0.006
  35. Hu LT, Perides G, Tanner LM, Klempner MS. Detection of a 130-kD matrix metalloproteinase in cerebrospinal fluid from a patient with Lyme neuroborreliosis. Clin Infect Dis. 1997 Jun; 24(6):1276-7.
    View in: PubMed
    Score: 0.005
  36. Shandilya S, Kurt Yilmaz N, Sadowski A, Monir E, Schiller ZA, Thomas WD, Klempner MS, Schiffer CA, Wang Y. Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions. J Mol Recognit. 2017 05; 30(5).
    View in: PubMed
    Score: 0.005
  37. Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA. Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J Infect Dis. 1996 Jul; 174(1):97-104.
    View in: PubMed
    Score: 0.005
  38. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996 May; 22(5):809-12.
    View in: PubMed
    Score: 0.005
  39. Perides G, Noring R, Klempner MS. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2. Biochem Biophys Res Commun. 1996 Feb 27; 219(3):690-5.
    View in: PubMed
    Score: 0.005
  40. Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KB, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science. 2016 Mar 04; 351(6277):1078-83.
    View in: PubMed
    Score: 0.005
  41. Hu LT, Perides G, Noring R, Klempner MS. Binding of human plasminogen to Borrelia burgdorferi. Infect Immun. 1995 Sep; 63(9):3491-6.
    View in: PubMed
    Score: 0.005
  42. Tang KS, Klempner MS, Wormser GP, Marques AR, Alaedini A. Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome. Clin Infect Dis. 2015 Dec 01; 61(11):1703-6.
    View in: PubMed
    Score: 0.005
  43. Klempner MS, Langdon LO. Training in infectious disease: planning for the future. Infect Agents Dis. 1995 Jun; 4(2):110-4.
    View in: PubMed
    Score: 0.005
  44. Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, Rogers RA. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis. 1995 May; 171(5):1258-65.
    View in: PubMed
    Score: 0.005
  45. Souders CA, Nelson SC, Wang Y, Crowley AR, Klempner MS, Thomas W. A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life. MAbs. 2015; 7(5):912-21.
    View in: PubMed
    Score: 0.005
  46. Stone DR, Estes NA, Klempner MS. Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Gu?rin. Clin Infect Dis. 1993 Jun; 16(6):825-6.
    View in: PubMed
    Score: 0.004
  47. Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis. 1993 May; 167(5):1074-81.
    View in: PubMed
    Score: 0.004
  48. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992 Aug; 166(2):440-4.
    View in: PubMed
    Score: 0.004
  49. Georgilis K, Noring R, Steere AC, Klempner MS. Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum. 1991 Jun; 34(6):770-5.
    View in: PubMed
    Score: 0.004
  50. Georgilis K, Steere AC, Klempner MS. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis. 1991 Jan; 163(1):150-5.
    View in: PubMed
    Score: 0.004
  51. Klempner MS, Noring R, Mier JW, Atkins MB. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med. 1990 Apr 05; 322(14):959-65.
    View in: PubMed
    Score: 0.003
  52. Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010 Aug; 24(6):1018-24.
    View in: PubMed
    Score: 0.003
  53. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA. 1988 Nov 11; 260(18):2682-5.
    View in: PubMed
    Score: 0.003
  54. Georgilis K, Klempner MS. In vitro effects of omega-3 fatty acids on neutrophil intracellular calcium homeostasis and receptor expression for FMLP and LTB4. Inflammation. 1988 Oct; 12(5):475-90.
    View in: PubMed
    Score: 0.003
  55. Styrt B, Schwartz MA, Klempner MS. Calcium release associated with discharge of specific granule contents from human neutrophils. Biochem Biophys Res Commun. 1988 Aug 15; 154(3):1308-13.
    View in: PubMed
    Score: 0.003
  56. Styrt B, Pollack CR, Klempner MS. An abnormal calcium uptake pump in Chediak-Higashi neutrophil lysosomes. J Leukoc Biol. 1988 Aug; 44(2):130-5.
    View in: PubMed
    Score: 0.003
  57. Ho JL, Klempner MS. Diminished activity of protein kinase C in tetanus toxin-treated macrophages and in the spinal cord of mice manifesting generalized tetanus intoxication. J Infect Dis. 1988 May; 157(5):925-33.
    View in: PubMed
    Score: 0.003
  58. Styrt B, Klempner MS. Lysosomotropic amines modulate neutrophil calcium homeostasis. J Cell Physiol. 1988 May; 135(2):309-16.
    View in: PubMed
    Score: 0.003
  59. Styrt B, Klempner MS. Lysosomotropic behavior of adrenergic antagonists in interactions with human neutrophils. Biochem Pharmacol. 1988 Feb 01; 37(3):435-41.
    View in: PubMed
    Score: 0.003
  60. Styrt B, Klempner MS. Effects of pH on killing of Staphylococcus aureus and Escherichia coli by constituents of the neutrophil phagolysosome. J Med Microbiol. 1988 Feb; 25(2):101-7.
    View in: PubMed
    Score: 0.003
  61. Styrt B, Rocklin RE, Klempner MS. Characterization of the neutrophil respiratory burst in atopy. J Allergy Clin Immunol. 1988 Jan; 81(1):20-6.
    View in: PubMed
    Score: 0.003
  62. Feder HM, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP, Sood S, Weinstein A, Wong SJ, Zemel L. A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007 Oct 04; 357(14):1422-30.
    View in: PubMed
    Score: 0.003
  63. Styrt B, Schwartz MA, Klempner MS. Linkage between neutrophil degranulation and calcium discharge. Biochem Biophys Res Commun. 1987 Aug 14; 146(3):1386-91.
    View in: PubMed
    Score: 0.003
  64. Georgilis K, Schaefer C, Dinarello CA, Klempner MS. Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils. J Immunol. 1987 May 15; 138(10):3403-7.
    View in: PubMed
    Score: 0.003
  65. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 01; 43(9):1089-134.
    View in: PubMed
    Score: 0.003
  66. Pollack C, Straley SC, Klempner MS. Probing the phagolysosomal environment of human macrophages with a Ca2+-responsive operon fusion in Yersinia pestis. Nature. 1986 Aug 28-Sep 3; 322(6082):834-6.
    View in: PubMed
    Score: 0.003
  67. Ho JL, Klempner MS. Inhibition of macrophage secretion by tetanus toxin is not directly linked to cytosolic calcium homeostasis. Biochem Biophys Res Commun. 1986 Feb 26; 135(1):16-24.
    View in: PubMed
    Score: 0.003
  68. Styrt B, Klempner MS. Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases. Blood. 1986 Feb; 67(2):334-42.
    View in: PubMed
    Score: 0.002
  69. Styrt B, Klempner MS. Modification of interactions between neutrophils and staphylococci by lysosomotropic weak bases. Infect Immun. 1985 Nov; 50(2):415-9.
    View in: PubMed
    Score: 0.002
  70. Ho JL, Klempner MS. Tetanus toxin inhibits secretion of lysosomal contents from human macrophages. J Infect Dis. 1985 Nov; 152(5):922-9.
    View in: PubMed
    Score: 0.002
  71. Styrt B, Rocklin RE, Klempner MS. Inhibition of neutrophil superoxide production by fanetizole. Inflammation. 1985 Sep; 9(3):233-44.
    View in: PubMed
    Score: 0.002
  72. Styrt B, Johnson PC, Klempner MS. Differential lysis of plasma membranes and granules of human neutrophils by digitonin. Tissue Cell. 1985; 17(6):793-800.
    View in: PubMed
    Score: 0.002
  73. Styrt B, Klempner MS. Leukocyte uptake of daunomycin. Drug Metab Dispos. 1984 Nov-Dec; 12(6):790-1.
    View in: PubMed
    Score: 0.002
  74. Styrt B, Klempner MS. Late-presenting variant of chronic granulomatous disease. Pediatr Infect Dis. 1984 Nov-Dec; 3(6):556-9.
    View in: PubMed
    Score: 0.002
  75. Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, Philipp MT. Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 2004 Aug; 23(8):615-8.
    View in: PubMed
    Score: 0.002
  76. Klempner MS, Styrt B. Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils. J Clin Invest. 1983 Nov; 72(5):1793-800.
    View in: PubMed
    Score: 0.002
  77. Klempner MS, Styrt B. Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function. J Antimicrob Chemother. 1983 Oct; 12 Suppl C:39-50.
    View in: PubMed
    Score: 0.002
  78. Klempner MS, Cendron M, Wyler DJ. Attachment of plasma membrane vesicles of human macrophages to Leishmania tropica promastigotes. J Infect Dis. 1983 Sep; 148(3):377-84.
    View in: PubMed
    Score: 0.002
  79. Klempner MS, Rocklin RE. Effects of leukocyte inhibitory factor (LIF) on human neutrophil function. Inflammation. 1983 Jun; 7(2):145-53.
    View in: PubMed
    Score: 0.002
  80. Styrt B, Klempner MS. Internal pH of human neutrophil lysosomes. FEBS Lett. 1982 Nov 22; 149(1):113-6.
    View in: PubMed
    Score: 0.002
  81. Klempner MS, Rocklin RE. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes. J Immunol. 1982 May; 128(5):2040-3.
    View in: PubMed
    Score: 0.002
  82. Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis. 1981 Nov; 144(5):472-9.
    View in: PubMed
    Score: 0.002
  83. Lin B, Kidder JM, Noring R, Steere AC, Klempner MS, Hu LT. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis. 2001 Jul 15; 184(2):174-80.
    View in: PubMed
    Score: 0.002
  84. Klempner MS, Mikkelsen RB, Corfman DH, Andr?-Schwartz J. Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J Cell Biol. 1980 Jul; 86(1):21-8.
    View in: PubMed
    Score: 0.002
  85. Klempner MS, Gallin JI, Balow JE, Van Kammen DP. The effect of hemodialysis and C5a des arg on neutrophil subpopulations. Blood. 1980 May; 55(5):777-83.
    View in: PubMed
    Score: 0.002
  86. Lin B, Noring R, Steere AC, Klempner MS, Hu LT. Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease. J Infect Dis. 2000 Mar; 181(3):1185-8.
    View in: PubMed
    Score: 0.002
  87. Klempner MS, Dinarello CA, Henderson WR, Gallin JI. Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest. 1979 Oct; 64(4):996-1002.
    View in: PubMed
    Score: 0.002
  88. Klempner MS, Gallin JI. Inhibition of neutrophil Fc receptor function by cotricosteroids. Clin Exp Immunol. 1978 Oct; 34(1):137-42.
    View in: PubMed
    Score: 0.002
  89. Bozza M, Kyvelos D, Trepicchio WL, Collins M, Klempner MS, Dorner AJ. Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro. J Interferon Cytokine Res. 1998 Oct; 18(10):889-95.
    View in: PubMed
    Score: 0.002
  90. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med. 1998 Jul 23; 339(4):216-22.
    View in: PubMed
    Score: 0.001
  91. Klempner MS, Dinarello CA, Gallin JI. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest. 1978 May; 61(5):1330-6.
    View in: PubMed
    Score: 0.001
  92. Joiner KA, Powderly WG, Blaser MJ, Klempner MS, Locksley RM, Mandell GL, Preheim LC, Remington JS, Slama TG, Steigbigel NH, Bartlett JG. Fellowship training in infectious diseases: a report from the regional and national meetings of infectious diseases division chiefs and program directors. Clin Infect Dis. 1998 May; 26(5):1060-5.
    View in: PubMed
    Score: 0.001
  93. McDermott DF, Trehu EG, Mier JW, Sorce D, Rand W, Ronayne L, Kappler K, Clancy M, Klempner M, Atkins MB. A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor. Clin Cancer Res. 1998 May; 4(5):1203-13.
    View in: PubMed
    Score: 0.001
  94. Klempner MS, Gallin JI. Separation and functional characterization of human neutrophil subpopulations. Blood. 1978 Apr; 51(4):659-69.
    View in: PubMed
    Score: 0.001
  95. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 1998 Mar 01; 82(5):923-30.
    View in: PubMed
    Score: 0.001
  96. Du Bois JS, Trehu EG, Mier JW, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W, Atkins MB. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. J Clin Oncol. 1997 Mar; 15(3):1052-62.
    View in: PubMed
    Score: 0.001
  97. Trehu EG, Mier JW, Dubois JS, Sorce D, Klempner MS, Epstein M, Dinarello CA, Shapiro L, Kappler K, Ronayne L, Atkins MB. Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. Clin Cancer Res. 1996 Aug; 2(8):1341-51.
    View in: PubMed
    Score: 0.001
  98. Katzen NA, Segal GM, Vannier E, Nerad JL, Klempner MS, Dinarello CA. Comparison of granulocyte-macrophage colony stimulating factor and interleukin-1 production from human peripheral blood mononuclear cells as measured by specific radioimmunoassays. Eur Cytokine Netw. 1992 Jul-Aug; 3(4):365-72.
    View in: PubMed
    Score: 0.001
  99. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med. 1991 Dec 19; 325(25):1786-90.
    View in: PubMed
    Score: 0.001
  100. Mier JW, Vachino G, Klempner MS, Aronson FR, Noring R, Smith S, Brandon EP, Laird W, Atkins MB. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15; 76(10):1933-40.
    View in: PubMed
    Score: 0.001
  101. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989 Feb 02; 320(5):265-71.
    View in: PubMed
    Score: 0.001
  102. Styrt B, Klempner MS, Rocklin RE. Comparison of prostaglandins E2 and D2 as inhibitors of respiratory burst in neutrophils from atopic and nonatopic subjects. Inflammation. 1988 Jun; 12(3):213-21.
    View in: PubMed
    Score: 0.001
  103. Dana N, Styrt B, Griffin JD, Todd RF, Klempner MS, Arnaout MA. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986 Nov 15; 137(10):3259-63.
    View in: PubMed
    Score: 0.001
  104. Borish L, O'Reilly D, Klempner MS, Rocklin RE. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine. J Immunol. 1986 Sep 15; 137(6):1897-903.
    View in: PubMed
    Score: 0.001
  105. Lad PM, Glovsky MM, Smiley PA, Klempner M, Reisinger DM, Richards JH. The beta-adrenergic receptor in the human neutrophil plasma membrane: receptor-cyclase uncoupling is associated with amplified GTP activation. J Immunol. 1984 Mar; 132(3):1466-71.
    View in: PubMed
    Score: 0.001
  106. Tonnesen MG, Klempner MS, Austen KF, Wintroub BU. Identification of a human neutrophil angiotension II-generating protease as cathepsin G. J Clin Invest. 1982 Jan; 69(1):25-30.
    View in: PubMed
    Score: 0.000
  107. Simon GL, Klempner MS, Kasper DL, Gorbach SL. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan; 145(1):72-7.
    View in: PubMed
    Score: 0.000
  108. Victor M, Weiss J, Klempner MS, Elsbach P. Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes. FEBS Lett. 1981 Dec 28; 136(2):298-300.
    View in: PubMed
    Score: 0.000
  109. Crowley CA, Curnutte JT, Rosin RE, Andr?-Schwartz J, Gallin JI, Klempner M, Snyderman R, Southwick FS, Stossel TP, Babior BM. An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med. 1980 May 22; 302(21):1163-8.
    View in: PubMed
    Score: 0.000
  110. Gallin JI, Wright DG, Malech HL, Davis JM, Klempner MS, Kirkpatrick CH. Disorders of phagocyte chemotaxis. Ann Intern Med. 1980 Apr; 92(4):520-38.
    View in: PubMed
    Score: 0.000
  111. Parrillo JE, Borst GC, Mazur MH, Iannini P, Klempner MS, Moellering RC, Anderson SE. Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis. N Engl J Med. 1979 Feb 08; 300(6):296-300.
    View in: PubMed
    Score: 0.000
  112. Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med. 1975 May; 58(5):644-54.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.